Supplementary Table 2 from The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with KRASG12C Inhibitors in Preclinical Models
收藏数据链接：
官方服务：
资源简介：
TP53 status and pathogenicity for each model utilized for this study. Mutation status was derived from DepMap (https://depmap.org/portal/) for cell lines or provided by the PDX CRO.
创建时间：
2025-02-05
